LEVETIRACETAM DEXCEL 500

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Aktiv bestanddel:

LEVETIRACETAM

Tilgængelig fra:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-kode:

N03AX14

Lægemiddelform:

TABLETS

Sammensætning:

LEVETIRACETAM 500 MG

Indgivelsesvej:

PER OS

Recept type:

Required

Fremstillet af:

DEXCEL LTD, ISRAEL

Terapeutisk gruppe:

LEVETIRACETAM

Terapeutisk område:

LEVETIRACETAM

Terapeutiske indikationer:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Autorisation dato:

2018-03-31